Clinical Trial: the Effect of Dexmedetomidine in Coracoid Approach Brachial Plexus Block

Study Status: Enrolling by invitation
Recruit Status: Enrolling by invitation
Study Type: Interventional

Official Title: the Effect of Dexmedetomidine in Coracoid Approach Brachial Plexus Block

Brief Summary: Dexmedetomidine is an α-2 adrenoreceptor agonist and has been extensively used through intravenous infusion，in order to improved the quality of block in regional anesthesia. In this prospective, randomized study, the authors focus on the effect of dexmedetomidine mixed with ropivacaine in coracoid approach brachial plexus block.

Detailed Summary:
Sponsor: The First Hospital of Qinhuangdao

Current Primary Outcome: duration time [ Time Frame: once per hour after surgery until 24 hours after surgery ]

effective analgesia time


Original Primary Outcome: Same as current

Current Secondary Outcome:

  • onset time [ Time Frame: 5,10,15,20,25,30 min after injection ]
  • Visual analogue scale [ Time Frame: 2,6,12,24hour after injection ]


Original Secondary Outcome: Same as current

Information By: The First Hospital of Qinhuangdao

Dates:
Date Received: October 22, 2016
Date Started: November 2016
Date Completion: May 2017
Last Updated: November 17, 2016
Last Verified: November 2016